A Phase II Study of AZD0530 for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Saracatinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 16 Mar 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.